Literature DB >> 8948356

CT-guided interstitial implantation of gynecologic malignancies.

B Erickson1, K Albano, M Gillin.   

Abstract

PURPOSE: To establish the efficacy of computed tomography (CT)-based planning and analysis of transperineal implants. METHODS AND MATERIALS: For patients with bulky disease or geometrically unfavorable anatomy, transperineal interstitial implantation of gynecologic tumors offers an alternative to standard intracavitary techniques. Control of dose rate and total dose distributions to produce a homogenous, low dose rate implant presents a challenge to the radiation oncologist in these complex implants, as does the relationship of these distributions to the patients's anatomy. We have used CT imaging following needle implantation, prior to source loading, in 25 patients (28 implants), as an aid in both the planning of the implant and the analysis of the dosimetry.
RESULTS: The spatial relationship between the needles and the normal anatomy can be clearly defined, despite the presence of some artifacts. Tumor volume is less clearly visualized but the adequacy of needle placement can be assessed and adjusted if necessary. Modifications of the planned source placement, based upon the location of specific needles and critical structures, can be made prior to loading the patient. Dose rate and total dose distributions are displayed with the appropriate anatomy on axial images and on reconstructed sagittal and coronal planes. Multiple points of dose specification for the rectum and the bladder are easily defined. Dose rate adjustment can be made by selectively changing the activity associated with a particular needle or needles. Multiple implants as well as external beam irradiation can also be integrated.
CONCLUSIONS: CT-based dosimetry has permitted intelligent planning decisions to be made prior to and during these implants. It has further allowed more accurate anatomically based dosimetric analysis, with visualization and control of dose rate and total dose distributions displayed together with the patient's anatomy. This more elaborate analysis should ultimately lead to a better understanding of the reasons for local control and complications and their relationships to dose rate, total dose, and volume.

Entities:  

Mesh:

Year:  1996        PMID: 8948356     DOI: 10.1016/s0360-3016(96)00373-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

1.  Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.

Authors:  Sophia C Kamran; Matthias M Manuel; Linda P Cho; Antonio L Damato; Ehud J Schmidt; Clare Tempany; Robert A Cormack; Akila N Viswanathan
Journal:  Gynecol Oncol       Date:  2017-03-18       Impact factor: 5.482

Review 2.  Imaging-guided brachytherapy for locally advanced cervical cancer: the main process and common techniques.

Authors:  Zhongshan Liu; Yangzhi Zhao; Yunfeng Li; Jing Sun; Xia Lin; Tiejun Wang; Jie Guo
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

3.  Use of transrectal ultrasound for high dose rate interstitial brachytherapy for patients of carcinoma of uterine cervix.

Authors:  Daya Nand Sharma; Goura Kisor Rath; Sanjay Thulkar; Sunesh Kumar; Vellaiyan Subramani; Parmod Kumar Julka
Journal:  J Gynecol Oncol       Date:  2010-03-31       Impact factor: 4.401

4.  Dosimetric consequences of interobserver variability in delineating the organs at risk in gynecologic interstitial brachytherapy.

Authors:  Antonio L Damato; Kanopkis Townamchai; Michele Albert; Ryan J Bair; Robert A Cormack; Joanne Jang; Arpad Kovacs; Larissa J Lee; Kimberley S Mak; Kristina L Mirabeau-Beale; Kent W Mouw; John G Phillips; Jennifer L Pretz; Andrea L Russo; John H Lewis; Akila N Viswanathan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-03       Impact factor: 7.038

5.  Validation of mathematical models for the prediction of organs-at-risk dosimetric metrics in high-dose-rate gynecologic interstitial brachytherapy.

Authors:  Antonio L Damato; Akila N Viswanathan; Robert A Cormack
Journal:  Med Phys       Date:  2013-10       Impact factor: 4.071

6.  Vaginal tolerance of CT based image-guided high-dose rate interstitial brachytherapy for gynecological malignancies.

Authors:  Naoya Murakami; Takahiro Kasamatsu; Minako Sumi; Ryoichi Yoshimura; Ken Harada; Mayuka Kitaguchi; Shuhei Sekii; Kana Takahashi; Kotaro Yoshio; Koji Inaba; Madoka Morota; Yoshinori Ito; Jun Itami
Journal:  Radiat Oncol       Date:  2014-01-23       Impact factor: 3.481

7.  A new template for MRI-based intracavitary/interstitial gynecologic brachytherapy: design and clinical implementation.

Authors:  Silvia Rodriguez Villalba; Jose Richart Sancho; Antonio Otal Palacin; Jose Perez Calatayud; Manuel Santos Ortega
Journal:  J Contemp Brachytherapy       Date:  2015-09-14

8.  Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.

Authors:  Zhong-Shan Liu; Jie Guo; Yang-Zhi Zhao; Xia Lin; Bing-Ya Zhang; Chu Zhang; Hong-Yong Wang; Lei Yu; Xiao-Jun Ren; Tie-Jun Wang
Journal:  Int J Gynecol Cancer       Date:  2017-05       Impact factor: 3.437

9.  A proposed protocol on HDR cylinder treatments: proof of avoidance of re-planning of CT based fractionated treatment, using a critical, statistical and graphical analysis of clinical data.

Authors:  Sadiq Malik; Parveen A Banu; Naheed Rukhsana; Mushfika Ahmed; Zebunnesa Yasmin
Journal:  J Contemp Brachytherapy       Date:  2012-09-29

10.  Institutional experience using interstitial brachytherapy for the treatment of primary and recurrent pelvic malignancies.

Authors:  Paul Aridgides; Benjamin Onderdonk; Mary Cunningham; Emily Daugherty; Lingyun Du; W Douglas Bunn; Rinki Agarwal; Seung Shin Hahn
Journal:  J Contemp Brachytherapy       Date:  2016-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.